MLICM
MRVL icon

Metropolitan Life Insurance Company (MetLife)’s Marvell Technology MRVL Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio MRVL Stock Details MRVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-16,342
Closed -$1.43M – 2519
2021
Q4 		$1.43M Buy
16,342
+45
+0.3% +$3.36K 0.02% 716
2021
Q3 		$983K Sell
16,297
-411
-2% -$24.6K 0.01% 968
2021
Q2 		$975K Buy
16,708
+3,208
+24% +$157K 0.01% 1024
2021
Q1 		$661K Buy
13,500
+522
+4% +$25.6K 0.01% 1241
2020
Q4 		$617K Sell
12,978
-265
-2% -$11.5K 0.01% 1230
2020
Q3 		$526K Sell
13,243
-188
-1% -$6.92K 0.01% 1186
2020
Q2 		$471K Sell
13,431
-2,668
-17% -$78.1K 0.01% 1249
2020
Q1 		$364K Buy
16,099
+1
+0% +$24 0.01% 1235
2019
Q4 		$428K Buy
16,098
+243
+2% +$6.16K 0.01% 1431
2019
Q3 		$396K Sell
15,855
-5,010
-24% -$126K 0.01% 1438
2019
Q2 		$498K Sell
20,865
-256
-1% -$5.98K 0.01% 1305
2019
Q1 		$420K Sell
21,121
-387
-2% -$7.23K 0.01% 1418
2018
Q4 		$348K Buy
21,508
+349
+2% +$5.78K 0.01% 1450
2018
Q3 		$408K Buy
21,159
+10,440
+97% +$215K 0.01% 1510
2018
Q2 		$230K Sell
10,719
-809
-7% -$17.3K ﹤0.01% 1852
2018
Q1 		$242K Buy
11,528
+20
+0.2% +$458 ﹤0.01% 1772
2017
Q4 		$247K Sell
11,508
-573
-5% -$11.7K ﹤0.01% 1776
2017
Q3 		$216K Buy
12,081
+1,104
+10% +$18.4K ﹤0.01% 2228
2017
Q2 		$181K Sell
10,977
-552
-5% -$8.93K ﹤0.01% 2396
2017
Q1 		$176K Hold
11,529
– – ﹤0.01% 2348
2016
Q4 		$160K Sell
11,529
-266
-2% -$3.62K ﹤0.01% 2472
2016
Q3 		$157K Sell
11,795
-114
-1% -$1.34K ﹤0.01% 2475
2016
Q2 		$113K Buy
+11,909
New +$119K ﹤0.01% 2582
2014
Q3 		– Sell
-11,988
Closed -$170K – 2705
2014
Q2 		$170K Buy
11,988
+600
+5% +$9.24K ﹤0.01% 2604
2014
Q1 		$179K Hold
11,388
– – ﹤0.01% 2527
2013
Q4 		$164K Hold
11,388
– – ﹤0.01% 2592
2013
Q3 		$131K Buy
11,388
+399
+4% +$4.92K ﹤0.01% 2646
2013
Q2 		$129K Buy
+10,989
New +$119K ﹤0.01% 2625

Other funds holding MRVL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s MRVL Position: Q1 2022 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Marvell Technology (MRVL) in Q1 2022, closing a stake of 16,342 shares — an estimated $1.43M sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in MRVL in Q2 2013 and held it in 28 quarters. The position peaked at $1.43M in Q4 2021. 914 funds tracked by Wall St. Rank hold MRVL as of Q1 2022.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Marvell Technology position as of Q1 2022 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 16,342 Marvell Technology shares in Q1 2022, an estimated $1.43M.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Marvell Technology in Q2 2013 and held it in 28 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Marvell Technology position peaked at $1.43M in Q4 2021.
  • 914 funds tracked by Wall St. Rank held Marvell Technology as of Q1 2022.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2022, filed 12 May 2022.